에 대한 최신 뉴스 CACI International (NYSE:CACI) 주식

CACI International

CACI International Inc is an information solutions and services provider, offering information solutions and services to its customers. The company's primary customers are agencies and departments of the U.S. government, which account for the vast majority of the firm's revenue. It provides information solutions and services supporting national security missions and government modernization for intelligence, defense, and federal civilian customers. Some of the services provided by the company are functional software development, data, and business analysis, IT operations support, naval architecture, and life cycle support intelligence among others. The company's operating segments are; Domestic operations and International operations. It derives key revenue from the Domestic segment.

Large Cap

News

Movers

ABBV

CACI

LDOS

MNDY

MPWR

MRNA

NVDA

PCVX

SMCI

XPEV

이들 10개 대형주는 지난주 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 1. 모놀리식 파워 시스템즈(NASDAQ:MPWR)의 주식은 24.68% 하락했다. 이는 엣지워터 리서치(Edgewater Research)의 분석 보고서에 따라 모놀리식의 엔비디아(NASDAQ:NVDA) 블랙웰(Blackwell) GPU에 대한 할당이 전력 관리 IC의 성능 문제로 위험에 처해 있다고 밝힌 후 발생한 일이다.

슈퍼 마이크로, 모더나 및 샤오펑은 지난주 최악의 성과를 보인 10개 대형주 중 일부 (11월 11일-15일)

CACI International, Inc. Class A Common Stock

CACI International Inc

These ten large-cap stocks were the worst performers in the last week. Are they in your portfolio?
<ol>
<li>Monolithic Power Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MPWR#NASDAQ">MPWR</a>) lost 24.68% last week as it was hit by an Edgewater Research analyst report that stated Monolithic's allocation to Nvidia's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) Blackwell GPUs is in jeopardy due to performance problems with its Power Management ICs.</li>
<li>Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) stock tumbled 24.23% after the company recently announced it could not file its quarterly report for the period ending <a href="https://www.benzinga.com//node/41938588" target="_blank" rel="noreferrer noopener">September 30, 2024, on time</a>.</li>
<li>Moderna Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) stock fell 21.31% last week amid <a href="https://www.benzinga.com//node/42013119" target="_blank" rel="noreferrer noopener">pressure on vaccine stocks</a> after President-elect Donald Trump nominated Robert F. Kennedy Jr. to lead the HHS.</li>
<li>Leidos Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>) shares dived 19.04%, probably because President-elect Trump made federal appointments during his transition period. Investors may evaluate the impact of possible cuts from the "<a href="https://www.benzinga.com//node/42013424" target="_blank" rel="noreferrer noopener">Department of Government Efficiency."</a></li>
<li>Monday.Com Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>) stock fell 18.94% last week <a href="https://www.benzinga.com//node/41877454" target="_blank" rel="noreferrer noopener">despite the company reporting</a> a Q3 beat and raising its annual outlook.</li>
<li>Vaxcyte, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCVX#NASDAQ">PCVX</a>) stock fell 18.60% last week amid <a href="https://www.benzinga.com//node/42013119" target="_blank" rel="noreferrer noopener">pressure on vaccine stocks</a> after President-elect Donald Trump nominated Robert F. Kennedy Jr. to lead the HHS.</li>
<li>Booz Allen Hamilton Holding Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAH#NYSE">BAH</a>) shares plummeted 18.59%.</li>
<li>AbbVie Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) stock declined 17.30% last week after it announced that its Phase 2 EMPOWER trials did not <a href="https://www.benzinga.com/general/biotech/24/11/41881546/abbvie-9billion-schizophrenia-studies-bristol-myers-stock-surges" target="_blank" rel="noreferrer noopener">meet their primary endpoints</a>.</li>
<li>CACI International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CACI#NYSE">CACI</a>) shares decreased 17.16%.</li>
<li>XPeng Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) shares dipped 16.89%, reflecting a broader trend in U.S.-listed Chinese stocks. This market shift may be influenced by concerns surrounding President-elect Trump's administration picks, which could <a href="https://www.benzinga.com//node/41946780" target="_blank" rel="noreferrer noopener">signal a tougher stance toward China</a>.</li>
</ol>
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/11/42026369/shopify-disney-and-coinbase-were-among-top-10-large-cap-gainers-last-week-november-11-15-are-the-others-in-your-portfolio" target="_blank" rel="noreferrer noopener">Shopify, Disney And Coinbase Were Among Top 10 Large Cap Gainers Last Week (November 11-15): Are The Others In Your Portfolio?</a></li>
</ul>
Image by Robert Way via Shutterstock

Super Micro Computer, Moderna And XPeng Were Among Top 10 Large Cap Stocks Losing Big Last Week (November 11-15): Check Out Other Losers

<a href="https://www.law360.com/trials/articles/2259735/breaking-jury-holds-caci-liable-for-42m-over-abu-ghraib-torture" title="https://www.law360.com/trials/articles/2259735/breaking-jury-holds-caci-liable-for-42m-over-abu-ghraib-torture">https://www.law360.com/trials/articles/2259735/breaking-jury-holds-caci-liable-for-42m-over-abu-ghraib-torture</a>

Legal

'Jury Holds CACI Liable For $42M Over Abu Ghraib Torture' - Law360

11 analysts have shared their evaluations of CACI International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CACI#NYSE">CACI</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $577.91, with a high estimate of $650.00 and a low estimate of $520.00. This current average reflects an increase of 11.35% from the previous average price target of $519.00. 
<img src="https://www.benzinga.com/files/images/story/2024/1731435068_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The perception of CACI International by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Strauss</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$625.00</td>
<td>$610.00</td>
</tr>
<tr>
<td>David Strauss</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$610.00</td>
<td>$500.00</td>
</tr>
<tr>
<td>Cai von Rumohr</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$570.00</td>
<td>$545.00</td>
</tr>
<tr>
<td>Gavin Parsons</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$520.00</td>
<td>$471.00</td>
</tr>
<tr>
<td>Tobey Sommer</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$650.00</td>
<td>$520.00</td>
</tr>
<tr>
<td>Peter Arment</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$640.00</td>
<td>$533.00</td>
</tr>
<tr>
<td>Seth Seifman</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$555.00</td>
<td>$520.00</td>
</tr>
<tr>
<td>Matthew Akers</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$577.00</td>
<td>$525.00</td>
</tr>
<tr>
<td>Mariana Perez Mora</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$555.00</td>
<td>$535.00</td>
</tr>
<tr>
<td>Tobey Sommer</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$520.00</td>
<td>$500.00</td>
</tr>
<tr>
<td>Mariana Perez Mora</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$535.00</td>
<td>$450.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to CACI International. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of CACI International compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of CACI International's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into CACI International's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/CACI/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on CACI International analyst ratings.</a>
<h2>Delving into CACI International's Background</h2>
CACI International Inc is an information solutions and services provider, offering information solutions and services to its customers. The company's primary customers are agencies and departments of the U.S. government, which account for the vast majority of the firm's revenue. It provides information solutions and services supporting national security missions and government modernization for intelligence, defense, and federal civilian customers. Some of the services provided by the company are functional software development, data, and business analysis, IT operations support, naval architecture, and life cycle support intelligence among others. The company's operating segments are; Domestic operations and International operations. It derives key revenue from the Domestic segment.
<h3>Financial Milestones: CACI International's Journey</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Revenue Growth: CACI International displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 11.17%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Industrials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: CACI International's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.84% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): CACI International's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 3.35%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): CACI International's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 1.72%, the company showcases efficient use of assets and strong financial health.
Debt Management: CACI International's debt-to-equity ratio is below the industry average. With a ratio of 0.6, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>What Are Analyst Ratings?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

The Analyst Verdict: CACI International In The Eyes Of 11 Experts

Barclays analyst David Strauss maintains CACI International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CACI#NYSE">CACI</a>) with a Overweight and raises the price target from $610 to $625.

Price Target

Barclays Maintains Overweight on CACI International, Raises Price Target to $625

CACI International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CACI#NYSE">CACI</a>) has outperformed the market over the past 10 years by 9.74% on an annualized basis producing an average annual return of 20.59%. Currently, CACI International has a market capitalization of $12.43 billion. 
Buying $1000 In CACI: If an investor had bought $1000 of CACI stock 10 years ago, it would be worth $6,618.80 today based on a price of $554.49 for CACI at the time of writing.
<h3>CACI International's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730818850_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$1000 Invested In This Stock 10 Years Ago Would Be Worth $6,600 Today

Contracts

CACI Secures Five-Year Task Order Valued At Up To $226M To Provide Expertise To U.S. Southern Command Operations

Barclays analyst David Strauss maintains CACI International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CACI#NYSE">CACI</a>) with a Overweight and raises the price target from $500 to $610.

Barclays Maintains Overweight on CACI International, Raises Price Target to $610

CACI International Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CACI#NYSE">CACI</a>) reported better-than-expected first-quarter financial results and issued FY25 revenue guidance above estimates, after the <a href="https://www.benzinga.com/quote/caci/earnings">closing bell on Wednesday.</a>
CACI International reported quarterly earnings of $5.93 per share which beat the analyst consensus estimate of $5.07 per share. The company reported quarterly sales of $2.057 billion which beat the analyst consensus estimate of $1.921 billion.
&#8220;In the first quarter, CACI delivered exceptional financial results across the board with revenue growth of 11%, healthy profitability and cash flow, and strong awards and backlog. In addition, we demonstrated our flexible and opportunistic approach to capital deployment by announcing two strategic acquisitions, Azure Summit Technology and Applied Insight,&#8221; said John Mengucci, CACI President and Chief Executive Officer. &#8220;Our continued momentum allows us to raise our fiscal year 2025 guidance. CACI is well positioned to continue driving long-term value for our customers and our shareholders.&#8221;
CACI International shares fell 0.7% to trade at $548.67 on Friday.
These analysts made changes to their price targets on Tyler Technologies following earnings announcement.
<ul>
<li>Baird analyst Peter Arment maintained CACI International with an Outperform and raised the price target from $533 to $640.</li>
<li>Truist Securities analyst Tobey Sommer reiterated CACI International with a Buy and raised the price target from $520 to $650.</li>
<li>Goldman Sachs analyst Gavin Parsons maintained CACI International with a Neutral and raised the price target from $471 to $520.</li>
<li>TD Cowen analyst Cai von Rumohr maintained the stock with a Buy and boosted the price target from $545 to $570.</li>
</ul>
Considering buying CACI stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="546" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/25151139/image-263-1024x546.png" alt="" class="wp-image-615211" style="width:679px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/25151139/image-263-1024x546.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/25151139/image-263-300x160.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/25151139/image-263-768x409.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/25151139/image-263.png 1195w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41543872/how-to-earn-500-a-month-from-waste-management-stock-ahead-of-q3-earnings">How To Earn $500 A Month From Waste Management Stock Ahead Of Q3 Earnings</a></li>
</ul>

Equities

Eurozone

Markets

These Analysts Boost Their Forecasts On CACI International Following Strong Q1 Results

TD Cowen analyst Cai von Rumohr maintains CACI International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CACI#NYSE">CACI</a>) with a Buy and raises the price target from $545 to $570.

TD Cowen Maintains Buy on CACI International, Raises Price Target to $570

Goldman Sachs analyst Gavin Parsons maintains CACI International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CACI#NYSE">CACI</a>) with a Neutral and raises the price target from $471 to $520.

Goldman Sachs Maintains Neutral on CACI International, Raises Price Target to $520

Truist Securities analyst Tobey Sommer reiterates CACI International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CACI#NYSE">CACI</a>) with a Buy and raises the price target from $520 to $650.

Reiteration

Truist Securities Reiterates Buy on CACI International, Raises Price Target to $650

Throughout the last three months, 7 analysts have evaluated CACI International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CACI#NYSE">CACI</a>), offering a diverse set of opinions from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $554.57, a high estimate of $640.00, and a low estimate of $500.00. Surpassing the previous average price target of $501.86, the current average has increased by 10.5%.
<img src="https://www.benzinga.com/files/images/story/2024/1729861210_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
A comprehensive examination of how financial experts perceive CACI International is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Peter Arment</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$640.00</td>
<td>$533.00</td>
</tr>
<tr>
<td>Seth Seifman</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$555.00</td>
<td>$520.00</td>
</tr>
<tr>
<td>Matthew Akers</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$577.00</td>
<td>$525.00</td>
</tr>
<tr>
<td>Mariana Perez Mora</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$555.00</td>
<td>$535.00</td>
</tr>
<tr>
<td>Tobey Sommer</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$520.00</td>
<td>$500.00</td>
</tr>
<tr>
<td>Mariana Perez Mora</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$535.00</td>
<td>$450.00</td>
</tr>
<tr>
<td>David Strauss</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$500.00</td>
<td>$450.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to CACI International. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of CACI International compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of CACI International's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Capture valuable insights into CACI International's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CACI/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on CACI International analyst ratings.</a>
<h2>Discovering CACI International: A Closer Look</h2>
CACI International Inc is an information solutions and services provider, offering information solutions and services to its customers. The company's primary customers are agencies and departments of the U.S. government, which account for the vast majority of the firm's revenue. It provides information solutions and services supporting national security missions and government modernization for intelligence, defense, and federal civilian customers. Some of the services provided by the company are functional software development, data, and business analysis, IT operations support, naval architecture, and life cycle support intelligence among others. The company's operating segments are; Domestic operations and International operations. It derives key revenue from the Domestic segment.
<h3>CACI International: Financial Performance Dissected</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Growth: CACI International's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of 0.91%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: CACI International's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.84% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): CACI International's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 3.35%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): CACI International's ROA stands out, surpassing industry averages. With an impressive ROA of 1.72%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.6.
<h2>Analyst Ratings: What Are They?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Where CACI International Stands With Analysts

Baird analyst Peter Arment maintains CACI International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CACI#NYSE">CACI</a>) with a Outperform and raises the price target from $533 to $640.

Baird Maintains Outperform on CACI International, Raises Price Target to $640

WIIM

CACI International shares are trading higher after the company reported better-than-expected Q1 financial results and issued FY25 revenue guidance above estimates.

Guidance

Caci Sees FY25 Revenue $8.10B-$8.30B Vs $8.06B Est; FY24 Adj. EPS $22.89-$23.78 Vs $23.13 Est.

CACI International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CACI#NYSE">CACI</a>) reported quarterly earnings of $5.93 per share which beat the analyst consensus estimate of $5.07 by 16.96 percent. The company reported quarterly sales of $2.057 billion which beat the analyst consensus estimate of $1.921 billion by 7.06 percent. This is a 11.19 percent increase over sales of $1.850 billion the same period last year.

Earnings

Earnings Beats

CACI International Q1 2025 Adj. EPS $5.93 Beats $5.07 Estimate, Sales $2.057B Beat $1.921B Estimate

CACI International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CACI#NYSE">CACI</a>) is preparing to release its quarterly earnings on Wednesday, 2024-10-23. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect CACI International to report an earnings per share (EPS) of $5.06.
The announcement from CACI International is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Overview of Past Earnings</h3>
The company's EPS beat by $0.68 in the last quarter, leading to a 3.05% increase in the share price on the following day.
Here's a look at CACI International's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>5.93</td>
<td>5.63</td>
<td>4.47</td>
<td>4.55</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>6.61</td>
<td>5.74</td>
<td>4.36</td>
<td>4.36</td>
</tr>
<tr>
<td>Price Change %</td>
<td>3.0%</td>
<td>6.0%</td>
<td>-2.0%</td>
<td>2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1729620106_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of CACI International were trading at $532.16 as of October 21. Over the last 52-week period, shares are up 64.36%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analyst Opinions on CACI International</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on CACI International.
A total of 6 analyst ratings have been received for CACI International, with the consensus rating being Buy. The average one-year price target stands at $540.33, suggesting a potential 1.54% upside.
<h3>Peer Ratings Overview</h3>
This comparison focuses on the analyst ratings and average 1-year price targets of Parsons, UL Solutions and KBR, three major players in the industry, shedding light on their relative performance expectations and market positioning.
<ul>
<li>As per analysts' assessments, Parsons is favoring an Outperform trajectory, with an average 1-year price target of $105.0, suggesting a potential 80.27% downside.</li>
<li>UL Solutions received a Neutral consensus from analysts, with an average 1-year price target of $53.5, implying a potential 89.95% downside.</li>
<li>Analysts currently favor an Buy trajectory for KBR, with an average 1-year price target of $76.33, suggesting a potential 85.66% downside.</li>
</ul>
<h3>Comprehensive Peer Analysis Summary</h3>
In the peer analysis summary, key metrics for Parsons, UL Solutions and KBR are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>CACI International</td>
<td>Buy</td>
<td>19.68%</td>
<td>$197.75M</td>
<td>3.91%</td>
</tr>
<tr>
<td>Parsons</td>
<td>Outperform</td>
<td>23.15%</td>
<td>$351.54M</td>
<td>3.17%</td>
</tr>
<tr>
<td>UL Solutions</td>
<td>Neutral</td>
<td>5.95%</td>
<td>$366M</td>
<td>14.03%</td>
</tr>
<tr>
<td>KBR</td>
<td>Buy</td>
<td>5.82%</td>
<td>$271M</td>
<td>7.54%</td>
</tr>
</tbody>
</table>

Key Takeaway:
CACI International ranks highest in Gross Profit among its peers. It is in the middle for Revenue Growth and Return on Equity.
<h3>Delving into CACI International's Background</h3>
CACI International Inc is an information solutions and services provider, offering information solutions and services to its customers. The company's primary customers are agencies and departments of the U.S. government, which account for the vast majority of the firm's revenue. It provides information solutions and services supporting national security missions and government modernization for intelligence, defense, and federal civilian customers. Some of the services provided by the company are functional software development, data, and business analysis, IT operations support, naval architecture, and life cycle support intelligence among others. The company's operating segments are; Domestic operations and International operations. It derives key revenue from the Domestic segment.
<h3>CACI International: Delving into Financials</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Positive Revenue Trend: Examining CACI International's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 19.68% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Industrials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 6.61%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): CACI International's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 3.91%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): CACI International's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.98% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: CACI International's debt-to-equity ratio is below the industry average at 0.55, reflecting a lower dependency on debt financing and a more conservative financial approach.
<a href="https://www.benzinga.com/quote/CACI/earnings">To track all earnings releases for CACI International visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CACI International's Earnings Outlook

CACI Awarded $805M Task Order To Provide Engineering Support And Technology To The US Navy's NavalX Office

CACI International's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CACI#NYSE">CACI</a>) short percent of float has risen 5.81% since its last report. The company recently reported that it has 178 thousand shares sold short, which is 0.91% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.56 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>CACI International Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728926120_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for CACI International has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing CACI International's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, CACI International's peer group average for short interest as a percentage of float is 2.77%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About CACI International?

CACI International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CACI#NYSE">CACI</a>) has outperformed the market over the past 15 years by 5.75% on an annualized basis producing an average annual return of 17.47%. Currently, CACI International has a market capitalization of $11.57 billion. 
Buying $1000 In CACI: If an investor had bought $1000 of CACI stock 15 years ago, it would be worth $11,196.52 today based on a price of $518.89 for CACI at the time of writing.
<h3>CACI International's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728666037_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 15 Years Ago Would Be Worth $11,000 Today

Caci International ( ($CACI) ) just unveiled an update. On October 30, 2024, CACI International Inc secured a $750 million Term Loan B Facility to ...

CACI International Secures Loan for Acquisition Financing

GM, Capital One top list of Buy-rated stocks with positive Q3 surprise

Wells Fargo analyst Matthew Akers has maintained their bullish stance on CACI stock, giving a Buy rating on October 29. Matthew Akers has given his...

Strategic Growth and Financial Performance Propel CACI International's Buy Rating

There's a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Sunnova Energy International (NOVA – Research Report...

Analysts Are Bullish on Top Technology Stocks: Sunnova Energy International (NOVA), Caci International (CACI)

Barclays analyst David Strauss raised the firm's price target on CACI (CACI) to $625 from $610 and keeps an Overweight rating on the shares followi...

CACI price target raised to $625 from $610 at Barclays

A federal jury has found that Virginia-based defense contractor CACI (CACI) shared responsibility with the U.S. Army for abusing detainees at Abu G...

CACI ordered to pay $42M over Abu Ghraib prison abuses, Washington Post reports

Baird Q3 2024 Small/Mid Cap Growth Equity Fund Commentary

BlackRock Global Equity Market Neutral Fund Q3 2024 Commentary

Defense, government contractor stocks shot down on sudden worries over Trump Pentagon

Fidelity Stock Selector Mid Cap Fund Q3 2024 Review

AAON

ACLS

ALAB

AMTM

APPF

AVDX

BOOT

BROS

BURL

BWIN

BWXT

CARR

CASY

CWAN

CYBR

DFEN

ESTC

EXLS

FANG

FITE

FIVE

FIVN

FOUR

INSP

IRTC

ISRG

JKHY

KLAC

KMPR

KNSL

LGIH

LSCC

MANH

MEDP

MSFT

NBIX

NOVA

ONTO

PCOR

PODD

POOL

PRCT

RPAY

RXST

SAIC

SITM

SMPL

TARS

TBBK

TOELF

TREX

VNOM

WFRD

WFTUF

Screenshot 2024-05-14 at 5.48.35 PM

Movers & Shakers

AMZN

GOOG

INTC

Contractor+ Is Leveling The Playing Field, Turning The Construction Industry On Its Head With Its Potentially Game-Changing AI-Driven App

Press Releases

CACI Awarded $314 Million Task Order to Provide Engineering Services to U.S. Navy Naval Undersea Warfare Center (NUWC)

CACI Acquires Applied Insight

CACI Schedules Fiscal Year 2025 First Quarter Conference Call

CACI Awarded $805 Million Task Order to Provide Engineering Support and Technology to U.S. Navy's NavalX Office

CACI Shareholders Elect Charles L. Szews to its Board of Directors

CACI Shareholders Elect Scott C. Morrison to its Board of Directors

CACI Reports Results for Its Fiscal 2025 First Quarter and Raises Fiscal Year Guidance

CACI President and CEO John Mengucci Receives the 2024 Technology Good Scout Award

CACI Completes Acquisition of Azure Summit Technology

CACI Awarded $226 Million Task Order to Provide Expertise to the U.S. Southern Command Operations (USSOUTHCOM)

Amentum Holdings

Booz Allen Hamilton Holding Corporation Common Stock

Booz Allen Hamilton

CBIZ

Clarivate

CRA Intl

Dun & Bradstreet Holdings, Inc. Common Stock

Dun & Bradstreet Hldgs

Equifax

Exponent

FTI Consulting

Huron Consulting Group Inc. - Common Stock

Huron Consulting Gr

ICF International

Innodata

Jacobs Solutions

Leidos Holdings

LegalZoom.com

NV5 Global

Planet Labs

Parsons

RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)

RELX

Science Applications International Corporation - Common Stock

Science Applications Intl

TransUnion

UL Solutions

Verisk Analytics

Willdan Group

Barclays

TD Cowen

Goldman Sachs

Truist Securities

Baird

CACI Intl

이들 10개 대형주는 지난주 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?
1. 모놀리식 파워 시스템즈(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MPWR#NASDAQ">MPWR</a>)의 주식은 24.68% 하락했다. 이는 엣지워터 리서치(Edgewater Research)의 분석 보고서에 따라 모놀리식의 엔비디아(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) 블랙웰(Blackwell) GPU에 대한 할당이 전력 관리 IC의 성능 문제로 위험에 처해 있다고 밝힌 후 발생한 일이다.
2. 슈퍼 마이크로 컴퓨터(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>)의 주식은 24.23% 하락했다. 이는 회사가 최근  <a href="https://www.benzinga.com//node/41938588" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">2024년 9월 30일 종료 분기 보고서를 제때</a> 제출할 수 없다고 발표한 후 주가가 급락했다.
3. 모더나(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>)의 주식은 21.31% 하락했다. 이는 도널드 트럼프 대통령 당선인이 로버트 F. 케네디 주니어를 보건복지부(HHS) 장관으로 지명한 후 <a href="https://www.benzinga.com//node/42013119" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">백신 주식에 대한 압박</a>이 발생했기 때문이다.
4. 레이도스 홀딩스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>)의 주식은 19.04% 하락했다. 이는 트럼프 대통령 당선인이 인수 기간 동안 연방 정부 주요직 임명을 했기 때문으로, 투자자들은 &#8220;<a href="https://www.benzinga.com//node/42013424" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">정부 효율성 부서</a>&#8220;에서의 가능한 삭감의 영향을 평가할 수 있다.
5. 먼데이닷컴(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>)의 주식은 회사가 3분기 실적이 예상치를 웃돌고 연간 전망을 상향 조정했음에도 <a href="https://www.benzinga.com//node/41877454" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">불구하고</a> 지난주 18.94% 하락했다.
6. 백스사이트(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCVX#NASDAQ">PCVX</a>)의 주식은 18.60% 하락했다. 이는 도널드 트럼프 대통령 당선인이 로버트 F. 케네디 주니어를 HHS 장관으로 지명한 후 백신 주식에 대한 압박이 발생했기 때문이다.
7. 부즈 앨런 해밀턴 홀딩(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAH#NYSE">BAH</a>)의 주식은 18.59% 하락했다.
8. 애브비(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>)의 주식은 17.30% 하락했다. 이는 2상 EMPOWER 시험이 <a href="https://www.benzinga.com/general/biotech/24/11/41881546/abbvie-9billion-schizophrenia-studies-bristol-myers-stock-surges" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">주요 목표</a>를 달성하지 못했다고 발표한 후 발생한 일이다.
9. CACI 인터내셔널(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CACI#NYSE">CACI</a>)의 주식은 17.16% 하락했다.
10. 샤오펑(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>)의 주식은 16.89% 하락했다. 이는 미국에 상장된 중국 주식의 광범위한 하락세를 반영한 것이다. 이러한 시장 변화는 트럼프 당선인의 행정부 인사를 둘러싼 우려의 영향을 받을 수 있으며, 이는 <a href="https://www.benzinga.com//node/41946780" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">중국에 대한 더욱 강경한 입장</a>을 나타낼 수 있다.
또한 읽어보세요:
<ul>
<li><a href="https://kr.benzinga.com/news/usa/stocks/%EC%87%BC%ED%94%BC%ED%8C%8C%EC%9D%B4-%EB%94%94%EC%A6%88%EB%8B%88-%EB%B0%8F-%EC%BD%94%EC%9D%B8%EB%B2%A0%EC%9D%B4%EC%8A%A4%EB%8A%94-%EC%A7%80%EB%82%9C%EC%A3%BC-%EC%B5%9C%EA%B3%A0-%EC%84%B1%EA%B3%BC/" target="_blank" rel="noopener">쇼피파이, 디즈니 및 코인베이스는 지난주 최고 성과를 보여준 10개 대형주 중 일부 (11월 11일-15일)</a></li>
</ul>
이미지 출처: Robert Way via Shutterstock
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

CACI International

뉴스

에 대한 최신 뉴스 CACI International (NYSE:CACI) 주식

일요일, 11월 17, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌